Tsunekazu Matsumoto
Kyoto University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Tsunekazu Matsumoto.
Hypertension | 1997
Masahisa Goto; Masashi Mukoyama; Shin Ichi Suga; Tsunekazu Matsumoto; Masayo Nakagawa; Rieko Ishibashi; Masato Kasahara; Akira Sugawara; Issei Tanaka; Kazuwa Nakao
Angiotensin II acts on at least two receptor subtypes, AT1 and AT2. Although the physiological role of the AT2 receptor is still poorly defined, it may be implicated in inhibition of cell growth, vasorelaxation, and apoptosis. In the present study, to investigate the role of the AT2 receptor in the kidney and its implication in hypertensive states, we examined its expression using cultured mesangial cells (MC) from normotensive Wistar-Kyoto rats (WKY) and from stroke-prone spontaneously hypertensive rats (SHRSP). Receptor binding assays were performed using a nonselective ligand, [Sar1,Ile8]angiotensin II, or AT2-selective CGP42112A. Binding assays revealed that MC from WKY exhibited both AT1 and AT2 receptors, the ratio of which was confluence-dependent. In contrast, MC from SHRSP, whose proliferation activity was much higher than those from WKY, showed only the AT1 subtype. In receptor binding and Northern blot analyses, expression of the AT2 receptor of WKY-MC was low in the growing state but significantly induced upon confluence to become abundant in the post-confluent state, whereas that of SHRSP-MC was undetectable in either state. Gene expressions of AT1A and AT1B receptors were not significantly altered in either strain during the time in culture. These results indicate that the mesangial AT2-receptor expression is growth-dependent and suggest a role in the inhibition of MC growth in WKY. Much lower expression of the AT2 receptor in MC from SHRSP may suggest involvement in their higher proliferation activity and possibly in consequent renal disorders.
Placenta | 1998
Norimasa Sagawa; Hiroaki Itoh; Tsunekazu Matsumoto; Hiroko Mise; Wenguang Liu; Mercy A. Nuamah; Shigeo Yura; Masatsune Fukuoka; Shingo Fujii; Yoshihiro Ogawa; Hiroaki Masuzaki; Kiminori Hosoda; Kazuwa Nakao
Summary These studies provide the first evidence for leptin as a novel placenta-derived hormone in humans, and suggests the physiologic and pathophysiologic significance of leptin in normal pregnancy and in pregnancies complicated with preeclampsia or gestational trophoblastic diseases. To elucidate the role of leptin in human pregnancy, further investigations on the following points are required. o 1. Mechanism of resistance to high plasma leptin levels during pregnancy has not been elucidated. Studies on down-regulation of leptin receptor and changes in the plasma concentrations of leptin binding protein, which is identical to soluble leptin receptor, Ob-Re, may provide an answer to this question. 2. Possible candidates of the biological significance of placenta-derived leptin in pregnancy may be; a) effects on maternal glucose and lipid metabolism, b) regulation of placental function, and c) effects on fetal growth and development. 3. Identification of distribution of leptin receptors in intra-uterine tissues is crucial to understand the role of placenta-derived leptin during pregnancy.
Placenta | 1999
Hiroaki Itoh; Norimasa Sagawa; Tsunekazu Matsumoto; Singo Fujii; Kazuwa Nakao; Ian M. Bird; Ronald R. Magness
Summary We have previoulsy demonstrated a 38-fold increase in cGMP secretion from the gravid ovine uterus, and a 2-fold increase in plasma and urinary cGMP levels. cGMP causes potent vasodilation and there are two major guanylate cyclases, cGMP production pathways, NO/sGC and natriuretic peptide/pGC-A/B pathways, in ovine UA. Pregnancy up-regulates both pathways, concomitantly with down-regulation of UA CR, contributing to the dramatic increase of cGMP production in ovine UA. This suggests a possible role for the local vascular guanylate system in the regulation of increased uterine blood flow during pregnancy.
Nature Medicine | 1997
Hiroaki Masuzaki; Yoshihiro Ogawa; Norimasa Sagawa; Kiminori Hosoda; Tsunekazu Matsumoto; Hiroko Mise; Haruo Nishimura; Yaunao Yoshimasa; Issei Tanaka; Takahide Mori; Kazuwa Nakao
The Journal of Clinical Endocrinology and Metabolism | 1998
Hiroko Mise; Norimasa Sagawa; Tsunekazu Matsumoto; Shigeo Yura; Hiroaki Itoh; Takahide Mori; Hiroaki Masuzaki; Kiminori Hosoda; Yoshihiro Ogawa; Kazuwa Nakao
Biochemical and Biophysical Research Communications | 1997
Tsunekazu Matsumoto; Norimasa Sagawa; Masahiro Yoshida; Takahide Mori; Issei Tanaka; Masashi Mukoyama; Masato Kotani; Kazuwa Nakao
The Journal of Clinical Endocrinology and Metabolism | 1998
Shigeo Yura; Norimasa Sagawa; Yoshihiro Ogawa; Hiroaki Masuzaki; Hiroko Mise; Tsunekazu Matsumoto; Ken Ebihara; Shingo Fujii; Kazuwa Nakao
The Journal of Clinical Endocrinology and Metabolism | 1996
Tsunekazu Matsumoto; Norimasa Sagawa; Masashi Mukoyama; Issey Tanaka; Hiroshi Itoh; Masahisa Goto; M Horiuchi; Victor J. Dzau; T Mori; Kazuwa Nakao
The Journal of Clinical Endocrinology and Metabolism | 2000
Masato Kotani; Issei Tanaka; Yoshihiro Ogawa; Takayoshi Suganami; Tsunekazu Matsumoto; Seiji Muro; Yuji Yamamoto; Akira Sugawara; Yasunao Yoshimasa; Norimasa Sagawa; Shuh Narumiya; Kazuwa Nakao
Biochemical and Biophysical Research Communications | 1993
Tsunekazu Matsumoto; Yoshiaki Okuno; Yukio Sugiura